Brian Hubbard
Vorstandsvorsitzender bei Anji Pharmaceuticals, Inc.
Aktive Positionen von Brian Hubbard
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Sprout Bioventures
 Sprout Bioventures Investment ManagersFinance Sprout Bioventures (Sprout Bioventures) is a venture capital firm founded in 1900. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01.01.2018 | - |
Anji Pharmaceuticals, Inc.
 Anji Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anji Pharmaceuticals, Inc. engages in discovery and development of medicines for human genetics. The company is headquartered in Cambridge, MA. | Vorstandsvorsitzender | 01.02.2018 | - |
Karriereverlauf von Brian Hubbard
Ehemalige bekannte Positionen von Brian Hubbard
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Dogma Therapeutics, Inc.
 Dogma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dogma Therapeutics, Inc. developing oral PCSK9 inhibitors to treat high cholesterol and cardiovascular disease. The company is headquartered in Boxford, MA. | Vorstandsvorsitzender | 01.08.2015 | 02.08.2020 |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Direktor der Forschung - Eigenkapital | 01.10.2011 | 02.08.2015 |
Merck Global Health Innovation LLC
 Merck Global Health Innovation LLC Investment ManagersFinance Merck Global Health Innovation LLC (Merck Global Health) is a venture capital subsidiary of Merck & Co., Inc. founded in 2010. The firm is headquartered in Rahway, New Jersey. | Direktor der Forschung - Eigenkapital | 01.03.2008 | 02.09.2011 |
| NOVARTIS AG | Direktor der Forschung - Eigenkapital | 01.01.2002 | 02.01.2008 |
Ausbildung von Brian Hubbard
| The College of William & Mary | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
| Harvard Medical School | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Schweiz | 2 |
Operativ
| Director of Research - Equity | 3 |
| Chief Executive Officer | 2 |
| Private Equity Investor | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 5 |
|---|---|
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
Merck Global Health Innovation LLC
Merck Global Health Innovation LLC Investment ManagersFinance Merck Global Health Innovation LLC (Merck Global Health) is a venture capital subsidiary of Merck & Co., Inc. founded in 2010. The firm is headquartered in Rahway, New Jersey. | Finance |
Sprout Bioventures
Sprout Bioventures Investment ManagersFinance Sprout Bioventures (Sprout Bioventures) is a venture capital firm founded in 1900. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Anji Pharmaceuticals, Inc.
Anji Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anji Pharmaceuticals, Inc. engages in discovery and development of medicines for human genetics. The company is headquartered in Cambridge, MA. | Health Technology |
Dogma Therapeutics, Inc.
Dogma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dogma Therapeutics, Inc. developing oral PCSK9 inhibitors to treat high cholesterol and cardiovascular disease. The company is headquartered in Boxford, MA. | Health Technology |
- Börse
- Insiders
- Brian Hubbard
- Erfahrung
